semaglutide prediabetes progression to diabetes step trial Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 Semaglutide in Patients with Obesity-Related

Several 20242025 systematic reviews and meta-analyses have compiled the cross-trial safety data set (PMID 39318607, PMID 40291085, PMID 40728138)

All medical services, including clinical evaluations, treatment planning, and prescribing decisions, are provided exclusively by Usable Health, PC and its affiliated professional medical practices

Coinfusion of lowdose GLP1 and glucagon in man results in a reduction in food intake

Association between ICS use and risk of hyperglycemia in COPD patients: Systematic review and meta-analysis

Data on ovarian cancer specifically are limited, but its biologically plausible that GLP-1 signalling could modulate tumour behaviour in certain contexts

While heartburn can be bothersome, it is typically manageable through dietary modifications, lifestyle adjustments, and when necessary, acid-suppressing medications